A detailed history of Virtu Financial LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Virtu Financial LLC holds 35,392 shares of HBIO stock, worth $75,738. This represents 0.01% of its overall portfolio holdings.

Number of Shares
35,392
Holding current value
$75,738
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$2.77 - $4.63 $98,035 - $163,864
35,392 New
35,392 $101,000
Q2 2023

Jul 27, 2023

BUY
$4.19 - $6.16 $83,829 - $123,243
20,007 New
20,007 $110,000
Q3 2022

Nov 07, 2022

BUY
$2.33 - $3.92 $41,741 - $70,226
17,915 New
17,915 $46,000
Q3 2019

Nov 20, 2019

SELL
$1.59 - $3.47 $68,827 - $150,209
-43,288 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$1.93 - $4.59 $83,545 - $198,691
43,288 New
43,288 $87,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.